Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Traits, Mood, and Subjective Wellbeing01:22

Traits, Mood, and Subjective Wellbeing

326
Subjective well-being (SWB) refers to an individual's self-evaluation of their overall life satisfaction, happiness, and fulfillment. This multifaceted construct is typically assessed by analyzing the balance of positive and negative emotions alongside perceptions of life satisfaction. Personality traits such as neuroticism and extraversion are strongly associated with variations in SWB, offering critical insights into the underlying mechanisms of emotional well-being.
Neuroticism and...
326
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.4K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.4K
Bone Disorders01:29

Bone Disorders

5.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.4K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.2K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.0K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.5K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Phenomenology of Bipolar Disorder With Substance Use Disorders: A Systematic Review.

Bipolar disorders·2026
Same author

Adverse maternal and neonatal effects associated with perinatal xylazine exposure: a systematic review.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

The Relationship Between Depression and Quality of Life in Children and Adolescents: A Systematic Review: Lien entre dépression et qualité de vie chez les enfants et les adolescents : Une revue systématique.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada's federal correctional system.

Canadian journal of public health = Revue canadienne de sante publique·2026
Same author

Developmental Timing, Substance Exposure, and Persistent Brain Change: Recontextualizing Cannabis, Stimulants, and Opioids Across an Extended Neurodevelopmental Window.

The American journal of psychiatry·2026

Related Experiment Video

Updated: Jan 30, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis
03:41

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

4.6K

Cannabis and Mood Disorders.

Aliya M Lucatch1, Alexandria S Coles1, Kevin P Hill2

  • 1Addictions Division, Centre for Addictions and Mental Health (CAMH), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA USA.

Current Addiction Reports
|January 16, 2019
PubMed
Summary

Cannabis use disorder (CUD) is more common in individuals with mood disorders like depression and bipolar disorder. More research is needed to understand this link and develop effective treatments for CUD in this population.

Keywords:
AntidepressantsBipolar DisorderCannabisCannabis Use DisorderMajor DepressionMood DisordersMood Stabilizers

More Related Videos

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.9K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.7K

Related Experiment Videos

Last Updated: Jan 30, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis
03:41

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

4.6K
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.9K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.7K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Public Health

Background:

  • Individuals with mood disorders, including major depressive disorder (MDD) and bipolar disorder (BD), exhibit higher prevalence rates of cannabis use and cannabis use disorder (CUD) compared to the general population.
  • The underlying reasons for this association and the potential therapeutic effects of cannabis or its components (THC, CBD) in these conditions remain unclear.
  • Current evidence for treating CUD in patients with mood disorders is limited, with psychotherapeutic interventions showing more promise than pharmacological ones.

Purpose of the Study:

  • To review the neurobiology, epidemiology, clinical impact, and treatment of cannabis use disorder (CUD) specifically within the context of mood disorders.
  • To synthesize current knowledge on the association between cannabis use and mood disorders.
  • To highlight gaps in understanding and treatment efficacy.

Main Methods:

  • Literature review of existing studies on cannabis use disorder and mood disorders.
  • Analysis of epidemiological data on comorbidity rates.
  • Evaluation of current treatment evidence for CUD in mood disorder populations.

Main Results:

  • Patients with major depressive disorder (MDD) and bipolar disorder (BD) show increased rates of cannabis use and CUD.
  • The mechanisms driving this comorbidity and the therapeutic potential of cannabis components (THC, CBD) are not well understood.
  • Treatment options for comorbid CUD and mood disorders are scarce, with psychotherapy favored over pharmacotherapy.

Conclusions:

  • A significant association exists between cannabis use and mood disorders, necessitating further investigation.
  • Enhanced understanding of the neurobiological mechanisms underlying this association is crucial.
  • Development of more effective and targeted treatments for CUD in individuals with mood disorders is a priority.